Clinical Trial

Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants

Name: Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants — clinical trial record (NCT06344065)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Record status

This record was last updated April 3, 2024 (before its estimated May 25, 2025 completion). Its status may not reflect the trial's current state.

Summary

The purpose of this study is to evaluate the safety and immunogenicity of the DTaP in 3-month-old infants.

Trial Details

NCT Number	NCT06344065
Lead Sponsor	Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Conditions	Healthy Volunteers
Enrollment	1,584 participants
Start Date	2023-12-21
Primary Completion	2025-05-25 (estimated)
Study Completion	2028-12-25 (estimated)
Updated on ClinicalTrials.gov	2024-04-03